WHO endorses new malaria vaccine for African infants
Health & Science
By
Denis Omondi
| May 28, 2024
A new malaria vaccine, R21, promises to bolster the fight against the disease in infants across Africa.
The vaccine has been approved by the World Health Organization (WHO) and will be included in the routine immunisation schedules of partner countries.
The United Nations Children’s Fund (UNICEF), in partnership with the Gavi Vaccine Alliance, has commenced the distribution of the vaccine.
The first batch of 43,000 R21 doses arrived in the Central African Republic on May 24, with an additional 120,000 doses ready for dispatch.
READ MORE
KRA could miss out on millions in tax revenue from Zuku sale
Banks rush to comply with CBK rule on spying customer deals
Varying standards curtail Kenyan insurers' regional foray
Kenya and Algeria to expand trade agreements, Mudavadi says
Report: How Kenya's weak labour market hurts economy
Humanitarian agency banks on annual learning event to drive innovation, growth
New KPCU advances Sh125 million cherry fund loans to coffee farmers
Tea farmers earn Sh648 million from weekly auction
Why Mbadi's budget review is all about lowering expectations
Why Kenya-Germany jobs deal is double-edged sword for workers
“Having two safe and effective vaccines means we have greater supply security and can be more confident about meeting countries’ needs,” said Gavi Chief Executive Officer Dr Sania Nishtar.
Director of Supply Division at UNICEF, Leila Pakkala, expressed her optimism regarding the impact of the new vaccine.
“Previous concerns about supply meeting demand are firmly behind us. Now our priority is for the vaccines to reach every child at risk,” she said.
The R21 vaccine will be administered alongside the existing RTS, S vaccine, which has been distributed to children in Kenya, Benin, Burkina Faso, Cameroon, Ghana, Liberia, Malawi, and Sierra Leone following a successful four-year pilot.
To date, Gavi has supplied over 4.3 million doses of RTS, S.
The introduction of R21 is expected to enhance the prevention and protection against malaria, a leading cause of death among African infants.
Nearly half a million children in the continent succumb to the disease each year.
UNICEF, Gavi, and WHO have assured that the new vaccine will be delivered to governments upon request, contingent on their commitment to include it in their immunisation programmes.
These organisations will also support the governments in implementing vaccination plans, training healthcare workers, raising community awareness, and ensuring access to appropriate vaccine storage facilities.
Countries set to receive the R21 vaccine shipments include Chad, Côte d’Ivoire, the Democratic Republic of Congo, Mozambique, Nigeria, South Sudan, and Uganda.
The health bodies are dedicated to ensuring that the vaccines reach every child at risk in these regions.
- KRA could miss out on millions in tax revenue from Zuku sale
- How taxpayers lost billions in edible oils scandal
- Kalonzo warns Mutula against reckless talk